Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and liver disease: a meta-analysis and systematic review
ZC Huang, CQ Li, XY Liu, ZC Cao, HY Jia… - … drugs and therapy, 2021 - Springer
Background Liver disease is associated with increased bleeding risk. The efficacy and
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …
Efficacy and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Liver Disease: a Meta-Analysis and Systematic Review.
ZC Huang, CQ Li, XY Liu, ZC Cao… - … Drugs & Therapy, 2021 - search.ebscohost.com
Background: Liver disease is associated with increased bleeding risk. The efficacy and
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …
Efficacy and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Liver Disease: a Meta-Analysis and Systematic Review
H Zhi-Chun, L Chang-Qing, L Xiao-Yu… - … Drugs and Therapy, 2021 - search.proquest.com
Background Liver disease is associated with increased bleeding risk. The efficacy and
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …
Efficacy and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Liver Disease: a Meta-Analysis and Systematic Review
ZC Huang, CQ Li, XY Liu, ZC Cao… - … drugs and therapy, 2021 - pubmed.ncbi.nlm.nih.gov
Background Liver disease is associated with increased bleeding risk. The efficacy and
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …
Efficacy and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Liver Disease: a Meta-Analysis and Systematic Review.
ZC Huang, CQ Li, XY Liu, ZC Cao, HY Jia… - … Drugs and Therapy, 2020 - europepmc.org
Background Liver disease is associated with increased bleeding risk. The efficacy and
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …
safety of direct oral anticoagulants (DOACs) is a subject of contention in atrial fibrillation (AF) …